Two new oral contraceptives are hitting the market

June 2001

Two new oral contraceptives are hitting the market...Cyclessa from Organon and Yasmin from Berlex.

Cyclessa is a new low-dose triphasic oral contraceptive. It contains less estrogen than Tri-Cyclen and other triphasic pills.

Cyclessa tablets contain 25 mcg/day of ethinyl estradiol...plus 0.1, 0.125, and 0.15 mg/day of desogestrel in each phase.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

The new national cholesterol guidelines
Vioxx (rofecoxib) can increase blood pressure MORE than Celebrex (celecoxib)
hepatotoxicity associated with Arava (leflunomide)
new albuterol inhaler called Ventolin HFA
patients on Allegra who say it doesn't work
Diabetes A1cNow, a new rapid test for glycosylated hemoglobin (HbA1c) that you can use in your office
Infectious Diseases new warning about the risk of congestive heart failure with Sporanox (itraconazole)
Infectious Diseases Twinrix, the first combination hepatitis A and B vaccine for adults
Neurontin (gabapentin) to PREVENT migraines
whether children with anxiety disorders should be treated with psychotropic drugs
Women's Health Wellbutrin SR (bupropion) to help boost sexual desire in women
Women's Health Two new oral contraceptives are hitting the market
Hematology & Oncology new cancer drug, Gleevec
Multiple Sclerosis managing SYMPTOMS of multiple sclerosis
Gastroenterology whether it makes sense to use BOTH an H2-blocker and a proton pump inhibitor (PPI) for GERD